Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients - Quiz - MDSpire

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

  • By

  • R E Clark

  • J Bell

  • J O Clark

  • B Braithwaite

  • U Vithanarachchi

  • N McGinnity

  • T Callaghan

  • S Francis

  • R Salim

  • October 31, 2014

  • 0 min

Share

Original Source(s)

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

  • by R E Clark, J Bell, J O Clark, B Braithwaite, U Vithanarachchi, N McGinnity, T Callaghan, S Francis, R Salim

  • October 31, 2014

Related Content

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry